{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:08:09Z","timestamp":1793747289344,"version":"4.6.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Factor XIII (FXIII) is a protein involved in blood clot stabilisation which also plays an important role in processes including trauma, wound healing, tissue repair, pregnancy, and even bone metabolism. Following surgery, low FXIII levels have been observed in patients with peri-operative blood loss and FXIII administration in those patients was associated with reduced blood transfusions. Furthermore, in patients with low FXIII levels, FXIII supplementation reduced the incidence of post-operative complications including disturbed wound healing. Increasing awareness of potentially low FXIII levels in specific patient populations could help identify patients with acquired FXIII deficiency; although opinions and protocols vary, a cut-off for FXIII activity of\u2009~\u200960\u201370% may be appropriate to diagnose acquired FXIII deficiency and guide supplementation. This narrative review discusses altered FXIII levels in trauma, surgery and wound healing, diagnostic approaches to detect FXIII deficiency and clinical guidance for the treatment of acquired FXIII deficiency.<\/jats:p>","DOI":"10.1186\/s13054-022-03940-2","type":"journal-article","created":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T20:02:58Z","timestamp":1648152178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing"],"prefix":"10.1186","volume":"26","author":[{"given":"Christian","family":"Kleber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Sablotzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Casu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Martin","family":"Thoms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Horter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C. F.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Birschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Maegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Sch\u00f6chl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Wilhelmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"issue":"3","key":"3940_CR1","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1152\/physrev.00016.2010","volume":"91","author":"L Muszbek","year":"2011","unstructured":"Muszbek L, Bereczky Z, Bagoly Z, Kom\u00e1romi I, Katona \u00c9. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev. 2011;91(3):931\u201372.","journal-title":"Physiol Rev"},{"issue":"15","key":"3940_CR2","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1073\/pnas.91.15.7296","volume":"91","author":"VC Yee","year":"1994","unstructured":"Yee VC, Pedersen LC, Le Trong I, Bishop PD, Stenkamp RE, Teller DC. Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII. Proc Natl Acad Sci U S A. 1994;91(15):7296\u2013300.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"3940_CR3","doi-asserted-by":"publisher","first-page":"12027","DOI":"10.1074\/jbc.M114.608570","volume":"290","author":"M Souri","year":"2015","unstructured":"Souri M, Osaki T, Ichinose A. The non-catalytic B subunit of coagulation factor XIII accelerates fibrin cross-linking. J Biol Chem. 2015;290(19):12027\u201339.","journal-title":"J Biol Chem"},{"issue":"1","key":"3940_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/jth.14348","volume":"17","author":"JL Mitchell","year":"2019","unstructured":"Mitchell JL, Mutch NJ. Let\u2019s cross-link: diverse functions of the promiscuous cellular transglutaminase factor XIII-A. J Thromb Haemost. 2019;17(1):19\u201330.","journal-title":"J Thromb Haemost"},{"issue":"23","key":"3940_CR5","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1182\/blood-2011-02-333203","volume":"117","author":"SR Fraser","year":"2011","unstructured":"Fraser SR, Booth NA, Mutch NJ. The antifibrinolytic function of factor XIII is exclusively expressed through \u03b12-antiplasmin cross-linking. Blood. 2011;117(23):6371\u20134.","journal-title":"Blood"},{"issue":"7","key":"3940_CR6","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/jth.13354","volume":"14","author":"DC Rijken","year":"2016","unstructured":"Rijken DC, Abdul S, Malfliet JJ, Leebeek FW, Uitte de Willige S. Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII. J Thromb Haemost. 2016;14(7):1453\u201361.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3940_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jth.12074","volume":"11","author":"V Schroeder","year":"2013","unstructured":"Schroeder V, Kohler HP. New developments in the area of factor XIII. J Thromb Haemost. 2013;11(2):234\u201344.","journal-title":"J Thromb Haemost"},{"issue":"1\u20132","key":"3940_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000093562","volume":"35","author":"A Inbal","year":"2006","unstructured":"Inbal A, Dardik R. Role of coagulation factor XIII (FXIII) in angiogenesis and tissue repair. Pathophysiol Haemost Thromb. 2006;35(1\u20132):162\u20135.","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"5","key":"3940_CR9","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/jth.12169","volume":"11","author":"C Soendergaard","year":"2013","unstructured":"Soendergaard C, Kvist PH, Seidelin JB, Nielsen OH. Tissue-regenerating functions of coagulation factor XIII. J Thromb Haemost. 2013;11(5):806\u201316.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3940_CR10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1160\/TH05-04-0291","volume":"94","author":"A Inbal","year":"2005","unstructured":"Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneitte G, et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost. 2005;94(2):432\u20137.","journal-title":"Thromb Haemost"},{"issue":"9","key":"3940_CR11","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1182\/blood-2011-02-337568","volume":"118","author":"TG Loof","year":"2011","unstructured":"Loof TG, M\u00f6rgelin M, Johansson L, Oehmcke S, Olin AI, Dickneite G, et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood. 2011;118(9):2589\u201398.","journal-title":"Blood"},{"issue":"2","key":"3940_CR12","doi-asserted-by":"publisher","first-page":"e1000763","DOI":"10.1371\/journal.ppat.1000763","volume":"6","author":"Z Wang","year":"2010","unstructured":"Wang Z, Wilhelmsson C, Hyrsl P, Loof TG, Dobes P, Klupp M, et al. Pathogen entrapment by transglutaminase\u2014a conserved early innate immune mechanism. PLoS Pathog. 2010;6(2):e1000763.","journal-title":"PLoS Pathog"},{"issue":"3","key":"3940_CR13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1161\/01.ATV.0000154137.21230.80","volume":"25","author":"R Dardik","year":"2005","unstructured":"Dardik R, Loscalzo J, Eskaraev R, Inbal A. Molecular mechanisms underlying the proangiogenic effect of factor XIII. Arterioscler Thromb Vasc Biol. 2005;25(3):526\u201332.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3940_CR14","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/01.ATV.19.8.2012","volume":"19","author":"RA Ariens","year":"1999","unstructured":"Ariens RA, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol. 1999;19:2012\u20136.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"3940_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5482\/HAMO-13-08-0046","volume":"34","author":"A Biswas","year":"2014","unstructured":"Biswas A, Ivaskevicius V, Thomas A, Oldenburg J. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Hamostaseologie. 2014;34(2):160\u20136.","journal-title":"Hamostaseologie"},{"issue":"1","key":"3940_CR16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bpa.2009.09.011","volume":"24","author":"W Korte","year":"2010","unstructured":"Korte W. FXIII in perioperative coagulation management. Best Pract Res Clin Anaesthesiol. 2010;24(1):85\u201393.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"6","key":"3940_CR17","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","volume":"57","author":"MTS Yan","year":"2018","unstructured":"Yan MTS, Rydz N, Goodyear D, Sholzberg M. Acquired factor XIII deficiency: a review. Transfus Apher Sci. 2018;57(6):724\u201330.","journal-title":"Transfus Apher Sci"},{"key":"3940_CR18","first-page":"642","volume":"105","author":"B Uea","year":"1980","unstructured":"Uea B. Reduction in wound healing disturbances by pre- and postoperative quantitative F XIII supplementation. Zentralblatt der Chirurgie. 1980;105:642\u201351.","journal-title":"Zentralblatt der Chirurgie"},{"key":"3940_CR19","unstructured":"Chaoui K, Ziemer S, Lammert H, Lammert I. Faktor-XIII-Prophylaxe und deren Einfluss auf Wundheilungsst\u00f6rungen nach Tumorresektionen im Kopf-Hals-Bereich. Klinische Aspekte des Faktor-XIII-Mangels Diagnostik, klinische Relevanz, klinische Forschung Karger, Basel. 1997:158\u201365."},{"issue":"1","key":"3940_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1272\/jnms.73.18","volume":"73","author":"I Fujita","year":"2006","unstructured":"Fujita I, Kiyama T, Mizutani T, Okuda T, Yoshiyuki T, Tokunaga A, et al. Factor XIII therapy of anastomotic leak, and circulating growth factors. J Nippon Med Sch. 2006;73(1):18\u201323.","journal-title":"J Nippon Med Sch"},{"issue":"3","key":"3940_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0090-3019(00)00308-6","volume":"54","author":"R Gerlach","year":"2000","unstructured":"Gerlach R, Raabe A, Zimmermann M, Siegemund A, Seifert V. Factor XIII deficiency and postoperative hemorrhage after neurosurgical procedures. Surg Neurol. 2000;54(3):260\u20134 (discussion 264\u20135).","journal-title":"Surg Neurol"},{"issue":"19","key":"3940_CR22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1055\/s-0028-1107880","volume":"99","author":"FW Gierhake","year":"1974","unstructured":"Gierhake FW, Papastavrou N, Zimmermann K, Bohn H, Schwick HG. Prophylaxis of post-operative disturbances of wound healing with factor XIII substitution (author\u2019s transl). Dtsch Med Wochenschr. 1974;99(19):1004\u20139.","journal-title":"Dtsch Med Wochenschr"},{"key":"3940_CR23","first-page":"83","volume":"37","author":"T Muto","year":"1997","unstructured":"Muto T, et al. Post-operative F XIII deficiency and wound healing disturbances. Die Gelben Hefte. 1997;37:83\u20137 (in German).","journal-title":"Die Gelben Hefte"},{"issue":"12","key":"3940_CR24","first-page":"803","volume":"55","author":"Y Mishima","year":"1984","unstructured":"Mishima Y, Nagao F, Ishibiki K, Matsuda M, Nakamura N. Factor XIII in the treatment of postoperative refractory wound-healing disorders. Results of a controlled study. Chirurg. 1984;55(12):803\u20138.","journal-title":"Chirurg"},{"key":"3940_CR25","unstructured":"Schramm W. FXIII and wound healing, prospective investigations and double-blind study. In: Proceedings from \u2018coagulation factor XIII, symposium' (1982). p. 117\u201328."},{"issue":"8","key":"3940_CR26","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00423-018-1736-4","volume":"403","author":"Y Takeda","year":"2018","unstructured":"Takeda Y, Mise Y, Ishizuka N, Harada S, Hayama B, Inoue Y, et al. Effect of early administration of coagulation factor XIII on fistula after pancreatic surgery: the FIPS randomized controlled trial. Langenbecks Arch Surg. 2018;403(8):933\u201340.","journal-title":"Langenbecks Arch Surg"},{"issue":"9219","key":"3940_CR27","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/S0140-6736(00)02333-3","volume":"355","author":"Y Herouy","year":"2000","unstructured":"Herouy Y, Hellstern MO, Vanscheidt W, Sch\u00f6pf E, Norgauer J. Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers. Lancet. 2000;355(9219):1970\u20131.","journal-title":"Lancet"},{"key":"3940_CR28","unstructured":"Wozniak G, Lutz H, Noll T, Alemany J. Treatment of chronic wounds with distinct secretion, by means of F XIII. III. Clinical modalities and results. Z Wundheilung 2001;6(20):11\u201314 (in German)."},{"issue":"2","key":"3940_CR29","first-page":"89","volume":"27","author":"M Peschen","year":"1998","unstructured":"Peschen M, Thimm C, Weyl A, Weiss JM, Kurz H, Augustin M, et al. Possible role of coagulation factor XIII in the pathogenesis of venous leg ulcers. Vasa. 1998;27(2):89\u201393.","journal-title":"Vasa"},{"key":"3940_CR30","unstructured":"Erlebach R, Hartung H. Einsatz von Faktor XIII bei Schwerstbrandverletzten. Klinische Aspekte des Faktor-XIII-Mangels, Diagnostik, klinische Relevanz, klinische Forschung Karger: Basel. 1999:89\u201392."},{"issue":"1","key":"3940_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1055\/s-2005-872853","volume":"54","author":"O Godje","year":"2006","unstructured":"Godje O, Gallmeier U, Schelian M, Grunewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg. 2006;54(1):26\u201333.","journal-title":"Thorac Cardiovasc Surg"},{"issue":"4","key":"3940_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jtcvs.2013.04.044","volume":"146","author":"K Karkouti","year":"2013","unstructured":"Karkouti K, von Heymann C, Jespersen CM, Korte W, Levy JH, Ranucci M, et al. Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. J Thorac Cardiovasc Surg. 2013;146(4):927\u201339.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"3940_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/ALN.0b013e318194b21e","volume":"110","author":"WC Korte","year":"2009","unstructured":"Korte WC, Szadkowski C, Gahler A, Gabi K, Kownacki E, Eder M, et al. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology. 2009;110(2):239\u201345.","journal-title":"Anesthesiology"},{"issue":"4","key":"3940_CR34","first-page":"765","volume":"102","author":"JH Levy","year":"2009","unstructured":"Levy JH, Gill R, Nussmeier NA, Olsen PS, Andersen HF, Booth FV, et al. Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. A preliminary report. Thromb Haemost. 2009;102(4):765\u201371.","journal-title":"Thromb Haemost"},{"issue":"6","key":"3940_CR35","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/01.STR.0000017219.83330.FF","volume":"33","author":"R Gerlach","year":"2002","unstructured":"Gerlach R, T\u00f6lle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002;33(6):1618\u201323.","journal-title":"Stroke"},{"issue":"3","key":"3940_CR36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1213\/ANE.0000000000000561","volume":"120","author":"OM Theusinger","year":"2015","unstructured":"Theusinger OM, Baulig W, Seifert B, Muller SM, Mariotti S, Spahn DR. Changes in coagulation in standard laboratory tests and ROTEM in trauma patients between on-scene and arrival in the emergency department. Anesth Analg. 2015;120(3):627\u201335.","journal-title":"Anesth Analg"},{"issue":"6","key":"3940_CR37","doi-asserted-by":"publisher","first-page":"R272","DOI":"10.1186\/cc10553","volume":"15","author":"PI Johansson","year":"2011","unstructured":"Johansson PI, S\u00f8rensen AM, Perner A, Welling KL, Wanscher M, Larsen CF, et al. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care. 2011;15(6):R272.","journal-title":"Crit Care"},{"issue":"2","key":"3940_CR38","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/j.jss.2010.12.001","volume":"166","author":"SB Zaets","year":"2011","unstructured":"Zaets SB, Xu DZ, Lu Q, Feketova E, Berezina TL, Malinina IV, et al. Recombinant factor XIII mitigates hemorrhagic shock-induced organ dysfunction. J Surg Res. 2011;166(2):e135\u201342.","journal-title":"J Surg Res"},{"issue":"4","key":"3940_CR39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/BCR.0b013e3182a228ee","volume":"35","author":"SB Zaets","year":"2014","unstructured":"Zaets SB, Xu DZ, Lu Q, Feketova E, Berezina TL, Malinina IV, et al. Does recombinant factor XIII eliminate early manifestations of multiple-organ injury after experimental burn similarly to gut ischemia-reperfusion injury or trauma-hemorrhagic shock? J Burn Care Res. 2014;35(4):328\u201336.","journal-title":"J Burn Care Res"},{"issue":"3","key":"3940_CR40","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/TA.0000000000001998","volume":"85","author":"F Nagashima","year":"2018","unstructured":"Nagashima F, Inoue S, Koami H, Miike T, Sakamoto Y, Kai K. High-dose Factor XIII administration induces effective hemostasis for trauma-associated coagulopathy (TAC) both in vitro and in rat hemorrhagic shock in vivo models. J Trauma Acute Care Surg. 2018;85(3):588\u201397.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"3940_CR41","doi-asserted-by":"publisher","first-page":"20116","DOI":"10.1038\/s41598-020-76782-z","volume":"10","author":"KYT Chan","year":"2020","unstructured":"Chan KYT, Yong ASM, Wang X, Ringgold KM, St John AE, Baylis JR, et al. The adhesion of clots in wounds contributes to hemostasis and can be enhanced by coagulation factor XIII. Sci Rep. 2020;10(1):20116.","journal-title":"Sci Rep"},{"issue":"2","key":"3940_CR42","first-page":"385","volume":"104","author":"OM Theusinger","year":"2010","unstructured":"Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR. In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost. 2010;104(2):385\u201391.","journal-title":"Thromb Haemost"},{"issue":"4","key":"3940_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1537-2995.2008.02021.x","volume":"49","author":"JS Caudill","year":"2009","unstructured":"Caudill JS, Nichols WL, Plumhoff EA, Schulte SL, Winters JL, Gastineau DA, et al. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Transfusion. 2009;49(4):765\u201370.","journal-title":"Transfusion"},{"issue":"11","key":"3940_CR44","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/anae.13920","volume":"72","author":"P Stein","year":"2017","unstructured":"Stein P, Kaserer A, Sprengel K, Wanner GA, Seifert B, Theusinger OM, et al. Change of transfusion and treatment paradigm in major trauma patients. Anaesthesia. 2017;72(11):1317\u201326.","journal-title":"Anaesthesia"},{"issue":"6","key":"3940_CR45","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","volume":"4","author":"P Innerhofer","year":"2017","unstructured":"Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, Hell T, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4(6):e258\u201371.","journal-title":"Lancet Haematol"},{"issue":"1","key":"3940_CR46","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13049-017-0463-0","volume":"26","author":"A Kaserer","year":"2018","unstructured":"Kaserer A, Casutt M, Sprengel K, Seifert B, Spahn DR, Stein P. Comparison of two different coagulation algorithms on the use of allogenic blood products and coagulation factors in severely injured trauma patients: a retrospective, multicentre, observational study. Scand J Trauma Resusc Emerg Med. 2018;26(1):4.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"2","key":"3940_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.5858\/arpa.2012-0639-RS","volume":"138","author":"A Tahlan","year":"2014","unstructured":"Tahlan A, Ahluwalia J. Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit. Arch Pathol Lab Med. 2014;138(2):278\u201381.","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"3940_CR48","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.hpb.2017.07.002","volume":"19","author":"N Watanabe","year":"2017","unstructured":"Watanabe N, Yokoyama Y, Ebata T, Sugawara G, Igami T, Mizuno T, et al. Clinical influence of preoperative factor XIII activity in patients undergoing pancreatoduodenectomy. HPB (Oxford). 2017;19(11):972\u20137.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"3940_CR49","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1213\/01.ANE.0000134800.46276.21","volume":"99","author":"P Wettstein","year":"2004","unstructured":"Wettstein P, Haeberli A, Stutz M, Rohner M, Corbetta C, Gabi K, et al. Decreased factor XIII availability for thrombin and early loss of clot firmness in patients with unexplained intraoperative bleeding. Anesth Analg. 2004;99(5):1564\u20139 (table of contents).","journal-title":"Anesth Analg"},{"issue":"2","key":"3940_CR50","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1016\/j.thromres.2010.05.028","volume":"126","author":"L Ternstrom","year":"2010","unstructured":"Ternstrom L, Radulovic V, Karlsson M, Baghaei F, Hyllner M, Bylock A, et al. Plasma activity of individual coagulation factors, hemodilution and blood loss after cardiac surgery: a prospective observational study. Thromb Res. 2010;126(2):e128\u201333.","journal-title":"Thromb Res"},{"issue":"8","key":"3940_CR51","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3390\/jcm9082456","volume":"9","author":"S Listyo","year":"2020","unstructured":"Listyo S, Forrest E, Graf L, Korte W. The need for red cell support during non-cardiac surgery is associated to pre-transfusion levels of FXIII and the platelet count. J Clin Med. 2020;9(8):2456.","journal-title":"J Clin Med"},{"issue":"8","key":"3940_CR52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/MBC.0000000000000953","volume":"31","author":"FA Chuliber","year":"2020","unstructured":"Chuliber FA, Schutz NP, Vi\u00f1uales ES, Penchasky DL, Otero V, Villagra Iturre MJ, et al. Nonimmune-acquired factor XIII deficiency: a cause of high volume and delayed postoperative hemorrhage. Blood Coagul Fibrinol. 2020;31(8):511\u20136.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3940_CR53","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jcrc.2019.11.012","volume":"56","author":"EH Adam","year":"2020","unstructured":"Adam EH, Meier J, Klee B, Zacharowski K, Meybohm P, Weber CF, et al. Factor XIII activity in patients requiring surgical re-exploration for bleeding after elective cardiac surgery\u2014a prospective case control study. J Crit Care. 2020;56:18\u201325.","journal-title":"J Crit Care"},{"key":"3940_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2482-14-109","volume":"14","author":"H Inoue","year":"2014","unstructured":"Inoue H, Nishiyama N, Mizuguchi S, Nagano K, Izumi N, Komatsu H, et al. Clinical value of exogenous factor XIII for prolonged air leak following pulmonary lobectomy: a case control study. BMC Surg. 2014;14:109.","journal-title":"BMC Surg"},{"issue":"3","key":"3940_CR55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF00308823","volume":"22","author":"H Saito","year":"1992","unstructured":"Saito H, Fukushima R, Kobori O, Kawano N, Muto T, Morioka Y. Marked and prolonged depression of factor XIII after esophageal resection. Surg Today. 1992;22(3):201\u20136.","journal-title":"Surg Today"},{"issue":"11","key":"3940_CR56","first-page":"1098","volume":"28","author":"T Hildenbrand","year":"2002","unstructured":"Hildenbrand T, Idzko M, Panther E, Norgauer J, Herouy Y. Treatment of nonhealing leg ulcers with fibrin-stabilizing factor XIII: a case report. Dermatol Surg. 2002;28(11):1098\u20139.","journal-title":"Dermatol Surg"},{"issue":"5","key":"3940_CR57","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1055\/s-2007-999044","volume":"22","author":"G Wozniak","year":"1996","unstructured":"Wozniak G, Dapper F, Alemany J. Factor XIII in ulcerative leg disease: background and preliminary clinical results. Semin Thromb Hemost. 1996;22(5):445\u201350.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"3940_CR58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2340\/00015555715557","volume":"71","author":"W Vanscheidt","year":"1991","unstructured":"Vanscheidt W, Hasler K, Wokalek H, Niedner R, Sch\u00f6pf E. Factor XIII-deficiency in the blood of venous leg ulcer patients. Acta Dermato-Venereol. 1991;71(1):55\u20137.","journal-title":"Acta Dermato-Venereol"},{"issue":"8","key":"3940_CR59","first-page":"520","volume":"48","author":"H Burkhardt","year":"1977","unstructured":"Burkhardt H, Zellner PR, M\u00f6ller I. Factor XIII deficiency in burns. Chirurg. 1977;48(8):520\u20133.","journal-title":"Chirurg"},{"key":"3940_CR60","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/sj.sc.3101092","volume":"39","author":"SWJ Becker","year":"2001","unstructured":"Becker SWJ, Weidt F, R\u00f6hl K. The role of plasma transglutaminase (F XIII) in wound healing of complicated pressure sores after spinal cord injury. Spinal Cord. 2001;39:114\u20137.","journal-title":"Spinal Cord"},{"key":"3940_CR61","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.09.2010.3342","author":"S Saigusa","year":"2011","unstructured":"Saigusa S, Yamamura T, Tanaka K, Ohi M, Kawamoto A, Kobayashi M, et al. Efficacy of administration of coagulation factor XIII with definitive surgery for multiple intractable enterocutaneous fistulae in a patient with decreased factor XIII activity. BMJ Case Rep. 2011. https:\/\/doi.org\/10.1136\/bcr.09.2010.3342.","journal-title":"BMJ Case Rep"},{"key":"3940_CR62","unstructured":"Knab J, Dissemond J. Successful therapy of gram-negative foot infection by extension of systemic therapy by F XIII. ZfW 04\/05;165\u20138 (in German)."},{"issue":"3","key":"3940_CR63","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.bjan.2017.11.004","volume":"68","author":"J Carneiro","year":"2018","unstructured":"Carneiro J, Alves J, Conde P, Xambre F, Almeida E, Marques C, et al. Factor XIII-guided treatment algorithm reduces blood transfusion in burn surgery. Rev Bras Anestesiol. 2018;68(3):238\u201343.","journal-title":"Rev Bras Anestesiol"},{"issue":"7","key":"3940_CR64","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/j.1538-7836.2011.04315.x","volume":"9","author":"HP Kohler","year":"2011","unstructured":"Kohler HP, Ichinose A, Seitz R, Ariens RA, Muszbek L. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost. 2011;9(7):1404\u20136.","journal-title":"J Thromb Haemost"},{"key":"3940_CR65","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.transci.2018.07.006","volume":"57","author":"A Michael","year":"2018","unstructured":"Michael A, Durda ASW, Kerlin BA. State of the art in factor XIII laboratory assessment. Transfus Apher Sci. 2018;57:700\u20134.","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"3940_CR66","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1080\/10245332.2015.1101975","volume":"21","author":"A Dorgalaleh","year":"2016","unstructured":"Dorgalaleh A, Tabibian S, Hosseini MS, Farshi Y, Roshanzamir F, Naderi M, et al. Diagnosis of factor XIII deficiency. Hematology. 2016;21(7):430\u20139.","journal-title":"Hematology"},{"issue":"4","key":"3940_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/MBC.0000000000000459","volume":"27","author":"A Dorgalaleh","year":"2016","unstructured":"Dorgalaleh A, Tabibian S, Hosseini S, Shamsizadeh M. Guidelines for laboratory diagnosis of factor XIII deficiency. Blood Coagul Fibrinol. 2016;27(4):361\u20134.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"3940_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/tme.12069","volume":"23","author":"E Grossmann","year":"2013","unstructured":"Grossmann E, Akyol D, Eder L, Hofmann B, Haneya A, Graf BM, et al. Thromboelastometric detection of clotting factor XIII deficiency in cardiac surgery patients. Transfus Med. 2013;23(6):407\u201315.","journal-title":"Transfus Med"},{"issue":"2","key":"3940_CR69","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5482\/ha-1132","volume":"31","author":"CF Weber","year":"2011","unstructured":"Weber CF, Sanders JO, Friedrich K, Gerlach R, Platz J, Miesbach W, et al. Role of thrombelastometry for the monitoring of factor XIII. A prospective observational study in neurosurgical patients. Hamostaseologie. 2011;31(2):111\u20137.","journal-title":"Hamostaseologie"},{"issue":"9_suppl","key":"3940_CR70","doi-asserted-by":"publisher","first-page":"136S","DOI":"10.1177\/1076029618797472","volume":"24","author":"C Raspe","year":"2018","unstructured":"Raspe C, Besch M, Charitos EI, Flother L, Bucher M, Ruckert F, et al. Rotational thromboelastometry for assessing bleeding complications and factor XIII deficiency in cardiac surgery patients. Clin Appl Thromb Hemost. 2018;24(9_suppl):136S-S144.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"3","key":"3940_CR71","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","volume":"91","author":"VA Ferraris","year":"2011","unstructured":"Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91(3):944\u201382.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"3940_CR72","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","volume":"34","author":"SA Kozek-Langenecker","year":"2017","unstructured":"Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol. 2017;34(6):332\u201395.","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"3940_CR73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/jth.13893","volume":"16","author":"A Godier","year":"2018","unstructured":"Godier A, Greinacher A, Faraoni D, Levy JH, Samama CM. Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(1):170\u20134.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3940_CR74","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000478106","volume":"45","author":"H Lier","year":"2018","unstructured":"Lier H, von Heymann C, Korte W, Schlembach D. Peripartum haemorrhage: haemostatic aspects of the new German PPH guideline. Transfus Med Hemother. 2018;45(2):127\u201335.","journal-title":"Transfus Med Hemother"},{"issue":"1","key":"3940_CR75","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1186\/s13054-019-2347-3","volume":"23","author":"DR Spahn","year":"2019","unstructured":"Spahn DR, Bouillon B, Cerny V, Duranteau J, Filipescu D, Hunt BJ, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care. 2019;23(1):984.","journal-title":"Crit Care"},{"key":"3940_CR76","unstructured":"CSL Behring. Corifact prescribing information. 2019."},{"issue":"5","key":"3940_CR77","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000446813","volume":"43","author":"C Solomon","year":"2016","unstructured":"Solomon C, Korte W, Fries D, Pendrak I, Joch C, Gr\u00f6ner A, et al. Safety of factor XIII concentrate: analysis of more than 20 years of pharmacovigilance data. Transfus Med Hemother. 2016;43(5):365\u201373.","journal-title":"Transfus Med Hemother"},{"issue":"6","key":"3940_CR78","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.3390\/ijms22063055","volume":"22","author":"FSM Alshehri","year":"2021","unstructured":"Alshehri FSM, Whyte CS, Mutch NJ. Factor XIII-A: an indispensable \u201cfactor\u201d in haemostasis and wound healing. Int J Mol Sci. 2021;22(6):3055.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"3940_CR79","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1177\/0267659115579714","volume":"30","author":"J Kalbhenn","year":"2015","unstructured":"Kalbhenn J, Wittau N, Schmutz A, Zieger B, Schmidt R. Identification of acquired coagulation disorders and effects of target-controlled coagulation factor substitution on the incidence and severity of spontaneous intracranial bleeding during veno-venous ECMO therapy. Perfusion. 2015;30(8):675\u201382.","journal-title":"Perfusion"},{"issue":"5","key":"3940_CR80","doi-asserted-by":"publisher","first-page":"e400","DOI":"10.1097\/CCM.0000000000004286","volume":"48","author":"T Granja","year":"2020","unstructured":"Granja T, Hohenstein K, Schussel P, Fischer C, Prufer T, Schibilsky D, et al. Multi-modal characterization of the coagulopathy associated with extracorporeal membrane oxygenation. Crit Care Med. 2020;48(5):e400\u20138.","journal-title":"Crit Care Med"},{"issue":"6","key":"3940_CR81","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/jcm10061203","volume":"10","author":"O Moerer","year":"2021","unstructured":"Moerer O, Huber-Petersen JF, Schaeper J, Binder C, Wand S. Factor XIII activity might already be impaired before veno-venous ECMO in ARDS patients: a prospective, observational single-center cohort study. J Clin Med. 2021;10(6):1203.","journal-title":"J Clin Med"},{"issue":"6","key":"3940_CR82","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1177\/02676591211001791","volume":"36","author":"J Kalbhenn","year":"2021","unstructured":"Kalbhenn J, Glonnegger H, Wilke M, Bansbach J, Zieger B. Hypercoagulopathy, acquired coagulation disorders and anticoagulation before, during and after extracorporeal membrane oxygenation in COVID-19: a case series. Perfusion. 2021;36(6):592\u2013602.","journal-title":"Perfusion"},{"issue":"12","key":"3940_CR83","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1055\/a-1450-8414","volume":"121","author":"FA von Meijenfeldt","year":"2021","unstructured":"von Meijenfeldt FA, Havervall S, Adelmeijer J, Lundstrom A, Magnusson M, Mackman N, et al. COVID-19 is associated with an acquired factor XIII deficiency. Thromb Haemost. 2021;121(12):1668\u20139.","journal-title":"Thromb Haemost"},{"issue":"1","key":"3940_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12959-021-00333-3","volume":"19","author":"Y Lichter","year":"2021","unstructured":"Lichter Y, Badelbayov T, Shalev I, Schvartz R, Szekely Y, Benisty D, et al. Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients. Thromb J. 2021;19(1):79.","journal-title":"Thromb J"},{"issue":"3","key":"3940_CR85","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000127940","volume":"9","author":"J Benfer","year":"1977","unstructured":"Benfer J, Struck H. Factor XIII and fracture healing. An experimental study. Eur Surg Res. 1977;9(3):217\u201323.","journal-title":"Eur Surg Res"},{"issue":"1","key":"3940_CR86","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3109\/17453678508992981","volume":"56","author":"L Claes","year":"1985","unstructured":"Claes L, Burri C, Gerngross H, Mutschler W. Bone healing stimulated by plasma factor XIII. Osteotomy experiments in sheep. Acta Orthop Scand. 1985;56(1):57\u201362.","journal-title":"Acta Orthop Scand"},{"issue":"6","key":"3940_CR87","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000201166","volume":"55","author":"R Seitz","year":"1994","unstructured":"Seitz R, Leugner F, Katschinski M, Immel A, Kraus M, Egbring R, et al. Ulcerative colitis and Crohn\u2019s disease: factor XIII, inflammation and haemostasis. Digestion. 1994;55(6):361\u20137.","journal-title":"Digestion"},{"issue":"6","key":"3940_CR88","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3109\/00365529509089793","volume":"30","author":"AA Van Bodegraven","year":"1995","unstructured":"Van Bodegraven AA, Tuynman HA, Schoorl M, Kruishoop AM, Bartels PC. Fibrinolytic split products, fibrinolysis, and factor XIII activity in inflammatory bowel disease. Scand J Gastroenterol. 1995;30(6):580\u20135.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"3940_CR89","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0049-3848(96)00060-6","volume":"82","author":"E Chiarantini","year":"1996","unstructured":"Chiarantini E, Valanzano R, Liotta AA, Cellai AP, Fedi S, Ilari I, et al. Hemostatic abnormalities in inflammatory bowel disease. Thromb Res. 1996;82(2):137\u201346.","journal-title":"Thromb Res"},{"issue":"3","key":"3940_CR90","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/00042737-200203000-00008","volume":"14","author":"M Hayat","year":"2002","unstructured":"Hayat M, Ari\u00ebns RA, Moayyedi P, Grant PJ, O\u2019Mahony S. Coagulation factor XIII and markers of thrombin generation and fibrinolysis in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14(3):249\u201356.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"6","key":"3940_CR91","first-page":"326","volume":"29","author":"AA Vrij","year":"1999","unstructured":"Vrij AA, Rijken J, van Wersch JW, Stockbr\u00fcgger RW. Differential behavior of coagulation factor XIII in patients with inflammatory bowel disease and in patients with giant cell arteritis. Haemostasis. 1999;29(6):326\u201335.","journal-title":"Haemostasis"},{"issue":"5","key":"3940_CR92","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1055\/s-2007-999045","volume":"22","author":"R Lorenz","year":"1996","unstructured":"Lorenz R, Olbert P, Born P. Factor XIII in chronic inflammatory bowel diseases. Semin Thromb Hemost. 1996;22(5):451\u20135.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"3940_CR93","first-page":"5","volume":"21","author":"R Lorenz","year":"1991","unstructured":"Lorenz R, Heinm\u00fcller M, Classen M, Tornieporth N, Gain T. Substitution of factor XIII: a therapeutic approach to ulcerative colitis. Haemostasis. 1991;21(1):5\u20139.","journal-title":"Haemostasis"},{"issue":"2","key":"3940_CR94","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF00320061","volume":"59","author":"R Suzuki","year":"1989","unstructured":"Suzuki R, Toda H, Takamura Y. Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut. 1989;59(2):162\u20134.","journal-title":"Blut"},{"issue":"8947","key":"3940_CR95","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(95)90428-X","volume":"345","author":"R Lorenz","year":"1995","unstructured":"Lorenz R, Born P, Olbert P, Classen M. Factor XIII substitution in ulcerative colitis. Lancet. 1995;345(8947):449\u201350.","journal-title":"Lancet"},{"issue":"10","key":"3940_CR96","first-page":"999","volume":"37","author":"N Bregenzer","year":"1999","unstructured":"Bregenzer N, Caesar I, Andus T, H\u00e4mling J, Malchow H, Schreiber S, et al. Lack of clinical efficacy of additional factor XIII treatment in patients with steroid refractory colitis. The Factor XIII Study Group. Z Gastroenterol. 1999;37(10):999\u20131004.","journal-title":"Z Gastroenterol"},{"key":"3940_CR97","doi-asserted-by":"publisher","first-page":"A1014","DOI":"10.1016\/S0016-5085(98)84125-5","volume":"114","author":"W Kruis","year":"1998","unstructured":"Kruis W, Malchow H, Behnke M, Emmrich J, H\u00e4mling J, Lorenz R. Additive factor XIII treatment for severe ulcerative colitis. A double blind placebo-controlled trial. Gastroenterology. 1998;114:A1014.","journal-title":"Gastroenterology"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03940-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-03940-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-03940-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:33:18Z","timestamp":1700357598000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-03940-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3940"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-03940-2","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"26 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Open Access funding by Projekt DEAL was not included in the original publication, this article has been updated.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}